1. Home
  2. ATYR vs GAIA Comparison

ATYR vs GAIA Comparison

Compare ATYR & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • GAIA
  • Stock Information
  • Founded
  • ATYR 2005
  • GAIA 1988
  • Country
  • ATYR United States
  • GAIA United States
  • Employees
  • ATYR N/A
  • GAIA N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • GAIA Movies/Entertainment
  • Sector
  • ATYR Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • ATYR 228.1M
  • GAIA 143.5M
  • IPO Year
  • ATYR 2015
  • GAIA 1999
  • Fundamental
  • Price
  • ATYR $3.30
  • GAIA $4.82
  • Analyst Decision
  • ATYR Strong Buy
  • GAIA Strong Buy
  • Analyst Count
  • ATYR 4
  • GAIA 1
  • Target Price
  • ATYR $19.25
  • GAIA $7.00
  • AVG Volume (30 Days)
  • ATYR 832.1K
  • GAIA 26.9K
  • Earning Date
  • ATYR 11-07-2024
  • GAIA 11-04-2024
  • Dividend Yield
  • ATYR N/A
  • GAIA N/A
  • EPS Growth
  • ATYR N/A
  • GAIA N/A
  • EPS
  • ATYR N/A
  • GAIA N/A
  • Revenue
  • ATYR $235,000.00
  • GAIA $86,644,000.00
  • Revenue This Year
  • ATYR N/A
  • GAIA $13.81
  • Revenue Next Year
  • ATYR $1,200.54
  • GAIA $14.30
  • P/E Ratio
  • ATYR N/A
  • GAIA N/A
  • Revenue Growth
  • ATYR N/A
  • GAIA 9.28
  • 52 Week Low
  • ATYR $1.34
  • GAIA $2.56
  • 52 Week High
  • ATYR $3.80
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 52.43
  • GAIA 35.94
  • Support Level
  • ATYR $3.05
  • GAIA $4.38
  • Resistance Level
  • ATYR $3.26
  • GAIA $6.15
  • Average True Range (ATR)
  • ATYR 0.22
  • GAIA 0.31
  • MACD
  • ATYR -0.03
  • GAIA -0.14
  • Stochastic Oscillator
  • ATYR 30.00
  • GAIA 24.86

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an international presence.

Share on Social Networks: